BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20653362)

  • 1. Intrapleural tissue plasminogen activator for the treatment of parapneumonic effusion.
    Hamblin SE; Furmanek DL
    Pharmacotherapy; 2010 Aug; 30(8):855-62. PubMed ID: 20653362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
    Israel EN; Blackmer AB
    Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
    Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
    Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children].
    Uyan AP; Ozyürek H; Yilmaz E
    Tuberk Toraks; 2003; 51(3):320-4. PubMed ID: 15143413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapleural fibrinolytic therapy in complicated parapneumonic effusion and empyema: present status.
    Barthwal MS
    Indian J Chest Dis Allied Sci; 2008; 50(3):277-82. PubMed ID: 18630794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural streptokinase for the treatment of complicated parapneumonic effusion and empyema in 2 newborns.
    Yigit AK; Yilmaz Y; Erdeve O; Gokce IK; Oguz SS; Uras N; Dilmen U
    J Pediatr Surg; 2012 Oct; 47(10):e41-4. PubMed ID: 23084230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parapneumonic pleural effusion and empyema.
    Koegelenberg CF; Diacon AH; Bolliger CT
    Respiration; 2008; 75(3):241-50. PubMed ID: 18367849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapleural urokinase treatment in children with complicated parapneumonic effusion.
    Chen JP; Lue KH; Liu SC; Cheng SL; Sheu JN
    Acta Paediatr Taiwan; 2006; 47(2):61-6. PubMed ID: 16927629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolysis treatment for loculated parapneumonic pleural effusion secondary to right lower lobe pneumonia.
    Merlo LG; Ansari S; Singh B; Teferedgin FF; Cervellione KL; Gintautas J; Babury MA
    Proc West Pharmacol Soc; 2009; 52():11-3. PubMed ID: 22128410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The approach to the patient with a parapneumonic effusion.
    Wrightson JM; Davies RJ
    Semin Respir Crit Care Med; 2010 Dec; 31(6):706-15. PubMed ID: 21213202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of fibrinolytic agents for draining intrapleural infections.
    Bouros D; Schiza S; Siafakas N
    Semin Respir Infect; 1999 Mar; 14(1):39-47. PubMed ID: 10197396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapleural streptokinase in complicated parapneumonic effusions and empyema.
    Barthwal MS; Deoskar RB; Rajan KE; Chatterjee RS
    Indian J Chest Dis Allied Sci; 2004; 46(4):257-61. PubMed ID: 15515826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study.
    Bouros D; Schiza S; Patsourakis G; Chalkiadakis G; Panagou P; Siafakas NM
    Am J Respir Crit Care Med; 1997 Jan; 155(1):291-5. PubMed ID: 9001327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy in complicated parapneumonic pleural effusions and thoracic empyema.
    Schiza SE; Antoniou KM; Economidou FN; Siafakas NM
    Pulm Pharmacol Ther; 2005; 18(6):381-9. PubMed ID: 15998594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema.
    Cameron R
    Cochrane Database Syst Rev; 2000; (3):CD002312. PubMed ID: 10908554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily vs. twice-daily intrapleural urokinase treatment of complicated parapneumonic effusion in paediatric patients: A randomised, prospective study.
    Wang JN; Yao CT; Yeh CN; Liu CC; Wu MH; Chuang HY; Wu JM
    Int J Clin Pract; 2006 Oct; 60(10):1225-30. PubMed ID: 16981967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parapneumonic effusions and empyema.
    Light RW
    Clin Chest Med; 1985 Mar; 6(1):55-62. PubMed ID: 3847302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapleural streptokinase in management of parapneumonic effusions. Report of series and review of literature.
    Mitchell ME; Alberts WM; Chandler KW; Goldman AL
    J Fla Med Assoc; 1989 Dec; 76(12):1019-22. PubMed ID: 2689573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.
    Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R
    Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.